BMY:NYSE
Bristol-Myers Squibb Co
$63.64
arrow_downward
-0.17%(-0.11) 1D
$63.66
arrow_upward
+0.03% (+0.020)bedtimeAfter hours
Closed: Sep 11, 4:00:04 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BMY...
Open
$64.15
High
$64.20
Low
$63.27
Mkt. cap
130.00B
Avg. vol.
10.16M
Volume
7.06M
Dividend
3.96%
Quarterly dividend
$0.63
Ex-dividend date
Jul 2, 2026
P/E ratio
14.02
52-wk high
$68.64
52-wk low
$42.52
EPS
$4.54
Beta
0.23
Shares outstanding
2.04B
No. of employees
32K
Open
$64.15
High
$64.20
Low
$63.27
Mkt. cap
130.00B
Avg. vol.
10.16M
Volume
7.06M
Dividend
3.96%
Quarterly dividend
$0.63
Ex-dividend date
Jul 2, 2026
P/E ratio
14.02
52-wk high
$68.64
52-wk low
$42.52
EPS
$4.54
Beta
0.23
Shares outstanding
2.04B
No. of employees
32K
News stories
From web sources and news partners
ad-hoc-news.de
·
21 minutes ago
Bristol Myers Squibb stock holds near analyst targets as 2026 guidance firms up
MarketBeat
·
3 hours ago
Bristol Myers Squibb Company $BMY Shares Bought by The Manufacturers Life Insurance Company
Zacks
·
21 hours ago
MRK Banks on Growing Pipeline & New Drugs to Offset Keytruda LOE
Simply Wall Street
·
1 day ago
Bristol Myers Squibb (BMY) Faces Fresh Patent Pressure In Cardiac Drug Fight
Profile
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
About Bristol-Myers Squibb Co
CEOChris Boerner
Employees32.5K
Founded1887
HeadquartersNew York, New York, United States
SectorPharmaceutical industry
Websitebms.com